Research & Innovation at GPM
Pioneering Next-Generation Cancer Research for Global Impact
At GPM, innovation drives transformation. Our research agenda focuses on generating new knowledge and tools that address the unique molecular and clinical characteristics of diverse populations. In collaboration with DKFZ, NCT, HI-STEM, and global partners, we aim to advance cancer biology, biomarker discovery, and therapeutic development, ultimately shaping precision medicine that benefits patients worldwide.
Our interdisciplinary approach leverages multi-omics technologies, computational biology, and translational science to generate impactful research outputs. By building globally relevant intellectual property and fostering clinical trials, GPM is laying the foundation for tomorrow’s personalized oncology breakthroughs.
Research & Innovation Highlights:
Developing Novel Research Hypothesis Based on Diverse Data:
Using comprehensive genomic, transcriptomic, and proteomic datasets, GPM formulates innovative research questions tailored to the genetic diversity of global cancer populations. This focus drives discovery of novel biomarkers and molecular mechanisms unique to underrepresented groups, addressing critical gaps in cancer biology.
Generating Global-Impact Technology and Intellectual Property:
GPM prioritizes producing cutting-edge technologies that advance global oncology knowledge and application. Our collaborative projects also aim to develop intellectual property with worldwide relevance, ensuring that discoveries translate into tangible clinical tools and technologies that support personalized treatment.
Driving Biomarker Discovery and Facilitating Clinical Trials:
Through integrated multi-omics analyses and translational research, GPM identifies novel biomarkers predictive of cancer progression, treatment response, and resistance. We actively promote the design and execution of biomarker-driven clinical trials with international partners to validate these findings and accelerate their clinical application.